Skip to Main Content

Paper Details

BFAST but be smart: bTMB remains an exploratory biomarker in NSCLC.
Nat Rev Clin Oncol
1
2023
Author NameAffiliation
Roy S HerbstYale Cancer Center, Yale School of Medicine
  • 1 - 1

Datasets

Release 1.2